tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Income Statement

Compare
123 Followers

Virax Biolabs Group Ltd. Class A Income Statement

Last quarter (Q2 2026), Virax Biolabs Group Ltd. Class A's total revenue was $1.61K, a decrease of -97.90% from the same quarter last year. In Q2, Virax Biolabs Group Ltd. Class A's net income was $-2.34M. See Virax Biolabs Group Ltd. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 6.33K$ 156.42K-$ 0.00$ 123.82K
Gross Profit
$ -53.07K$ 50.59K-$ 0.00$ -9.43K
Operating Expenses
$ 6.11M$ 6.55M$ 5.73M$ 1.73M$ 635.10K
Depreciation and Amortization
$ 343.39K$ 103.10K$ 0.00$ 1.73M$ 644.54K
EBITDA
$ -5.80M$ -6.61M$ -5.44M$ -750.00$ 0.00
Operating Income
$ -6.16M$ -6.50M$ -5.73M$ -1.73M$ -644.54K
Other Income/Expenses
$ -41.00K$ -242.65K$ 275.00K$ -16.19K$ -28.38K
Pretax Income
$ -6.20M$ -6.74M$ -5.46M$ -1.75M$ -672.91K
Net Income
$ -6.06M$ -6.73M$ -5.46M$ -1.71M$ -650.98K
Per Share Metrics
Basic EPS
$ -1.96$ -3.36$ -5.13$ -1.50$ -0.57
Diluted EPS
$ -1.95$ -3.36$ -5.13$ -1.50$ -0.57
Weighted Average Shares Outstanding
3.10M 2.01M 1.06M 1.14M 1.14M
Weighted Average Shares Outstanding (Diluted)
3.10M 2.01M 1.06M 1.14M 1.14M
Currency in USD

Virax Biolabs Group Ltd. Class A Earnings and Revenue History